ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,888Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 2604

$552K Total Retail Price of All Prescriptions

Rank: 152 out of 2604

506 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 506 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 589 422 1 3
SIMVASTATIN 509 400 2 2
OMEPRAZOLE 471 319 3 5
HYDROCHLOROTHIAZIDE 425 360 4 10
HYDROCODONE-ACETAMINOPHEN 363 210 S3 5 1
ATENOLOL 299 234 6 11
LEVOTHYROXINE SODIUM 297 202 7 4
METFORMIN HCL 221 166 8 7
NAPROXEN 182 121 9 76
METOPROLOL TARTRATE 181 137 10 9
SERTRALINE HCL 167 99 11 23
PRAVASTATIN SODIUM 165 136 12 14
TRAMADOL HCL 161 114 13 15
FLUTICASONE PROPIONATE 160 92 14 31
FUROSEMIDE 155 141 15 8
WARFARIN SODIUM 150 122 16 13
RANITIDINE HCL 142 105 17 25
GABAPENTIN 141 104 18 12
DONEPEZIL HCL 135 85 19 28
AMLODIPINE BESYLATE 134 105 20 6
ALENDRONATE SODIUM 124 105 21 29
PROAIR HFA 121 114 22 27
ATORVASTATIN CALCIUM 119 93 23 19
LOSARTAN POTASSIUM 109 97 24 20
VENLAFAXINE HCL ER 108 58 25 107
PAROXETINE HCL 90 45 26 62
TAMSULOSIN HCL 90 55 26 30
LOVASTATIN 86 73 28 24
NAMENDA 78 66 29 37
TRICOR 77 27 30 132
ADVAIR DISKUS 76 41 31 41
GLIPIZIDE ER 76 55 31 134
NEXIUM 71 38 33 53
CYCLOBENZAPRINE HCL 70 34 R 34 43
SPIRIVA 66 53 35 45
KLOR-CON M20 64 53 36 86
MORPHINE SULFATE ER 63 11 S2 37 58
ROPINIROLE HCL 61 31 38 102
VERAPAMIL ER 58 48 39 117
GLYBURIDE 58 50 R 39 83
POLYETHYLENE GLYCOL 3350 58 30 39 42
ALLOPURINOL 56 50 42 35
CYMBALTA 56 30 42 44
GLIPIZIDE XL 55 31 44 144
PREDNISONE 55 42 44 34
SINGULAIR 55 21 44 120
ZETIA 52 37 47 94
IBUPROFEN 52 24 47 32
BUPROPION HCL SR 51 29 49 158
LORAZEPAM 51 41 49 190
BETAMETHASONE VALERATE 50 43 51 210
DIVALPROEX SODIUM 50 37 51 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.